Middle East & Africa Gastrointestinal Drugs Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

No. of Pages: 140    |    Report Code: TIPRE00016306    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Gastrointestinal Drugs Market

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Middle East and Africa Gastrointestinal Drugs Market – By Drug Class

1.3.2        Middle East and Africa Gastrointestinal Drugs Market – By Route of Administration

1.3.3        Middle East and Africa Gastrointestinal Drugs Market – By Application

1.3.4        Middle East and Africa Gastrointestinal drugs Market – By Distribution Channel

1.3.5        Middle East and Africa Gastrointestinal drugs Market – By Country

2.          Middle East and Africa Gastrointestinal Drugs Market  Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Middle East and Africa Gastrointestinal Drugs Market  Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Gastrointestinal Drugs Market - Middle East and Africa PEST Analysis

4.3        Expert Opinion

5.          Middle East and Africa Gastrointestinal Drugs Market  Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Rise in Prevalence of Gastrointestinal (GI) Diseases

5.1.2        Increase in Development of Biologics

5.2        Market Restraints

5.2.1        Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies

5.3        Market Opportunities

5.3.1        Increasing Investment in Research Activities and Growing Pipeline of GI Candidates

5.4        Future Trends

5.4.1        Emergence of Biosimilars

5.5        Impact Analysis

6.          Gastrointestinal Drugs Market – Middle East and Africa Analysis

6.1        Middle East and Africa Gastrointestinal Drugs Market Revenue Forecasts and Analysis

7.          Middle East and Africa Gastrointestinal Drugs Market Analysis And Forecasts To 2027 – By Drug Class

7.1        Overview

7.2        Middle East and Africa Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

7.2.1        Middle East and Africa Gastrointestinal drugs Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

7.3        Acid Neutralizers

7.3.1        Overview

7.3.2        Middle East and Africa Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)

7.4        Antidiarrheal and Laxatives

7.4.1        Overview

7.4.2        Middle East and Africa Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

7.5        Anti-Inflammatory Drugs

7.5.1        Overview

7.5.2        Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

7.6        Antiemetic and Antinauseants

7.6.1        Overview

7.6.2        Middle East and Africa Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)

7.7        Biologics

7.7.1        Overview

7.7.2        Middle East and Africa Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

7.8        Others

7.8.1        Overview

7.8.2        Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.          Middle East and Africa Gastrointestinal Drugs Market Analysis – By Route of Administration

8.1        Overview

8.2        Middle East and Africa Gastrointestinal Drugs Market, By Route of Administration 2019-2027 (%)

8.2.1        Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

8.3        Oral

8.3.1        Overview

8.3.2        Middle East and Africa Oral Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Parenteral

8.4.1        Overview

8.4.2        Middle East and Africa Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Middle East and Africa Gastrointestinal Drugs Market Analysis – By Application

9.1        Overview

9.2        Middle East and Africa Gastrointestinal Drugs Market, By Application 2019-2027 (%)

9.2.1        Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3        Inflammatory Ulcerative Colitis

9.3.1        Overview

9.3.2        Middle East and Africa Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4        Crohn's Disease

9.4.1        Overview

9.4.2        Middle East and Africa Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Irritable Bowel Syndrome

9.5.1        Overview

9.5.2        Middle East and Africa Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Gastroenteritis

9.6.1        Overview

9.6.2        Middle East and Africa Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Celiac Disease

9.7.1        Overview

9.7.2        Middle East and Africa Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.8        Others

9.8.1        Overview

9.8.2        Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.       Middle East and Africa Gastrointestinal Drugs Market Analysis – By Distribution Channel

10.1      Overview

10.2      Middle East and Africa Gastrointestinal Drugs Market, By Distribution Channel 2019-2027 (%)

10.2.1     Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3      Hospital Pharmacies

10.3.1     Overview

10.3.2     Middle East and Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.4      Retail Pharmacies

10.4.1     Overview

10.4.2     Middle East and Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.5      Online Pharmacies

10.5.1     Overview

10.5.2     Middle East and Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

11.       Gastrointestinal Drugs Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027

11.1.1     Overview

11.1.2     Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

11.1.2.1       Middle East & Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.2.2       Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.2.3       Middle East & Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.2.4       Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.3     Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

11.1.3.1       Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.1.1       Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.2       Saudi Arabia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.3.3       Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027(USD Million)

11.1.3.4       Saudi Arabia Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.3.5       Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.3.6       UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.6.1       UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.7       UAE Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.3.8       UAE Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.3.9       UAE Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.3.10    UAE Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.2      South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

11.2.1     South Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)

11.2.1.1       South Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.2.1.2       South Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.2.1.3       South Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.2.1.4       South Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.3      Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

11.3.1     Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)

11.3.1.1       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.3.1.2       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.3.1.3       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.3.1.4       Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12.       Impact of COVID-19 Pandemic on Middle East and Africa Gastrointestinal Drugs Market

12.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.       Company Profiles

13.1      Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Celltrion Healthcare Co.,Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AstraZeneca

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.       Appendix

14.1      Glossary of Terms

LIST OF TABLES

Table 1.            Middle East and Africa Gastrointestinal drugs Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)

Table 2.            Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 3.            Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 4.            Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 5.            Middle East & Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 6.            Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 7.            Middle East & Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027  (USD Million)

Table 8.            Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.            Saudi Arabia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 11.          Saudi Arabia Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 12.          Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          UAE Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 14.          UAE Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 15.          UAE Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 16.          UAE Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          South Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 18.          South Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 19.          South Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 20.          South Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 22.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 23.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 24.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          Glossary of Terms, Gastrointestinal Drugs Market

LIST OF FIGURES

Figure 1.           Gastrointestinal Drugs Market Segmentation

Figure 2.           Middle East and Africa Gastrointestinal Drugs Market Overview

Figure 3.           Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market

Figure 4.           Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Middle East and Africa Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)

Figure 6.           Gastrointestinal Drugs Market - Middle East and Africa PEST Analysis

Figure 7.           Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint

Figure 8.           Middle East and Africa Gastrointestinal Drugs market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Middle East and Africa Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

Figure 10.        Middle East and Africa Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Middle East and Africa Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Middle East and Africa Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Middle East and Africa Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Middle East and Africa Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)

Figure 17.        Middle East and Africa Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Middle East and Africa Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Middle East and Africa Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)

Figure 20.        Middle East and Africa Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Middle East and Africa Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Middle East and Africa Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Middle East and Africa Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Middle East and Africa Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Middle East and Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)

Figure 27.        Middle East and Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Middle East and Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        Middle East and Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        Middle East & Africa: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        Middle East & Africa Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 32.        Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

Figure 33.        Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        South Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.        Rest of Middle East and Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Middle East And Africa

 

The List of Companies - Middle East & Africa Gastrointestinal Drugs Market

  1. Johnson and Johnson Services, Inc.
  2. GlaxoSmithKline plc
  3. Celltrion Healthcare Co.,Ltd.
  4. AstraZeneca
  5. Takeda Pharmaceutical Company Limited